Mitigation of coagulation by removing clotting factors part 1: In vitro feasibility study

ASAIO Journal

Volumn 53, Issue 4, 2007, Pages 415-420

  Parker, Jared T ^a   Beutler, David S ^b   Sukavaneshvar, Sivaprasad ^b,c   Jacobs, Nathan ^b   Solen, Kenneth A ^a   Mohammad, Syed F ^b,c,d  

^a Brigham Young University   (United States)

^b Thrombodyne Inc   (United States)

^c Utah Artificial Heart Institute   (United States)

^d UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADSORPTION; BLOOD; COAGULATION; ENZYME INHIBITION; PATIENT MONITORING; PLASMAS; PROTEINS;

CLOTTING FACTORS; FEASIBILITY STUDY; FIBER CARTRIDGE; PROTAMINE-IMMOBILIZED SEPHAROSE MATRIX (PSM);

BLOOD VESSELS;

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADSORPTION; ANIMAL CELL; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; FEASIBILITY STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; NORMAL HUMAN; PARTIAL THROMBOPLASTIN TIME;

ADSORPTION; ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BLOOD PHYSIOLOGY; BLOOD PROTEINS; CATTLE; FEASIBILITY STUDIES; HUMANS; MICROSPHERES; MODELS, CARDIOVASCULAR; PARTIAL THROMBOPLASTIN TIME; PROTAMINES; PROTEIN C; PROTEIN S; PROTHROMBIN TIME; SEPHAROSE; STRESS, MECHANICAL; SWINE; SWINE, MINIATURE;

EID: 34547664795     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e3180cab642     Document Type: Article

References (17)

1. Arnoletti JP, Whitman GJ: Heparin-induced thrombocytopenia in coronary bypass surgery. Ann Thorac Surg 68: 576-578, 1999.
2. Cohen M: Heparin-induced thrombocytopenia and the clinical use of low molecular weight heparins in acute coronary syndromes. Semin Hematol 36: 33-36, 1999.
3. Kasirajan V, Smedira NG, McCarthy JF, et al: Risk factors for intracranial hemorrhage in adults on extracorporeal membrane oxygenation. Eur J Cardiothorac Surg 15: 508-514, 1999.
4. Ballard JO: Anticoagulant-induced thrombosis. JAMA 282: 310-312, 1999.
5. Ocal A, Kiris I, Erdinc M, et al: Efficiency of prostacyclin in the treatment of protamine-mediated right ventricular failure and acute pulmonary hypertension. Tohoku J Exp Med 207: 51-58, 2005.
6. Shapira N, Schaff HV, Piehler JM, et al: Cardiovascular effects of protamine sulfate in man. Thorac Cardiovasc Surg 84: 505-514, 1984.
7. Viaro F, Dalio M, Evora P: Catastrophic cardiovascular adverse reactions to protamine are nitric oxide/cyclic guanosine monophosphate dependent and endothelium mediated. Chest 122: 1061-1066, 2002.
8. Zwischenberger JB, Tao W, Deyo DJ, et al: Safety and efficacy of a heparin removal device: a prospective randomized preclinical outcomes study. Ann Thorac Surg 71: 270-272, 2001.
9. Weiler JM, Gellhaus MA, Carter JG, et al: A prospective study of the risk of an immediate adverse reaction to protamine sulfate during cardiopulmonary bypass surgery. J Allergy Clin Immunol 85: 713-719, 1990.
10. van Wyk V, Neethling WM, Badenhorst PN, Kotze HF: r-Hirudin inhibits platelet-dependent thrombosis during cardiopulmonary bypass in baboons. J Cardiovasc Surg (Torino) 39: 633-639, 1998.
11. Song X, Huhle G, Wang L, et al: Generation of anti-hirudin antibodies in heparin-induced thrombocytopenic patients treated with r-hirudin. Circulation 100: 1528-1532, 1999.
12. Cabanas R, Caballero MT, Lopez-Serrano MC, et al: Delayed hypersensitivity to enoxaparin. J Invest Allergol Clin Immunol 8: 383-384, 1998.
13. Gibaldi M, Wittkowsky AK: Contemporary use of and future roles for heparin in antithrombotic therapy: J Clin Pharmacol 35: 1031-1045, 1995.
14. Sogawa M, Mohammad SF: Anticoagulation of blood in vivo without heparin. Thromb Haemost 69: 936(Abstract No. 1429), 1993.
15. Sogawa M, Parr C, Mohammad SF: Anticoagulation of circulating blood by selective removal of clotting factors. ASAIO Abstracts 22: 102(Abstract), 1993.
16. Axen R, Porath J, Ernback S: Chemical coupling of peptides and proteins to polysaccharides by means of cyanogen halides. Nature 214: 1302-1304, 1967.
17. Cooper TG. The tools of biochemistry. New York, John Wiley & Sons, Inc., 1977.